GENE ONLINE|News &
Opinion
Blog

2026-06-10|

Claritas Rx White Paper Identifies Unified Consent Management as Essential for Specialty Therapy CRM Systems

by GOAI
Share To

A new white paper from Claritas Rx, titled “The Omnichannel Gap: Building the CRM of the Future for Patient Services,” outlines the necessity for modernized customer relationship management (CRM) systems to handle the complexities of specialty therapies. Karishma Desai, Associate Director of Data Strategy at Claritas Rx, identifies the unification of consent management as a primary requirement for these systems to function effectively within the current healthcare landscape.

The report details how organizations can address operational challenges by integrating artificial intelligence into the patient journey and automating workflows at scale. According to the findings, these technological implementations aim to enhance collaboration among various stakeholders involved in patient care. The paper suggests that by streamlining these processes, organizations may reduce administrative delays, improve treatment adherence, and facilitate more consistent patient outcomes. Claritas Rx has made the full white paper available for download to provide further technical insights into these strategies.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 20, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Codon-Pair Deoptimization Attenuates FMDV in Swine but Fails to Induce Protective Immunity
2026-07-16
Grady Emerson and Maddie DiMaria Named 2025-2026 Gatorade National Players of the Year
2026-07-15
Longitudinal Network Analysis Tracks Evolving Symptom Clusters in Elderly Chronic Gastritis Patients
2026-07-15
Taiwan Study Finds Allergic Disease Multimorbidity Patterns Shift During Elementary School Years
2026-07-15
NHS Data Shows 30-Fold Disparity in Specialty Training Success Rates Between Ethnic Groups
2026-07-15
New Jersey Meteorite Confirmed to Contain Extraterrestrial Chemical Signatures
2026-07-15
Vanda Pharmaceuticals Sponsors No. 47 IndyCar to Mark 47-Year Gap in Motion Sickness Treatments
2026-07-15
Scroll to Top